Container of remdesivir in a Gilead laboratory
Shares in pharmaceutical and biotech companies are coming to the fore in the hope of protection against the corona virus. But in this difficult-to-understand industry, investors should take several pieces of advice to heart.
Dhe legendary co-founder of the software company SAP, Dietmar Hopp, turned 80 on Sunday, which even earned him congratulations from the Federal President. It is particularly noteworthy that Frank-Walter Steinmeier also talks about an investment by Hopp that has become known in these wild times: “With your work as a founder and patron you are changing the lives of many people,” the Federal President is quoted as saying. “In these times, we are watching your biotech company’s progress in developing a vaccine against the terrible coronavirus.”
This means the relatively young pharmaceutical company Curevac. In Tübingen, it is working flat out on a vaccine against the new coronavirus. Curevac is not yet on the stock market, but there are also many other listed pharmaceutical and biotech companies whose stocks have come under heavy scrutiny in the hope of vaccines and cures for the coronavirus. These include giants like the American company Gilead, or more agile speed boats like the Mainz company Biontech.